Evidence map›Paper›PMID 29950404›Full record

ArticleCirculation2018

Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus.

David A McAllister, Stephanie H Read, Jan Kerssens, Shona Livingstone, Stuart McGurnaghan, Pardeep Jhund, John Petrie, Naveed Sattar, Colin Fischbacher, Soren Lund Kristensen and 3 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04791826 (Evaluation of an EMR-Based Clinical Decision Support Tool for the Implementation of Guideline-Directed Therapies for Prevention of Heart Failure Among High-Risk Patients With Type 2 Diabetes), which is not on this map. Cited by 101 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 6 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04791826 nacompletednot on this mapstarted 2021, after this paper: background citation

Evaluation of an EMR-Based Clinical Decision Support Tool for the Implementation of Guideline-Directed Therapies for Prevention of Heart Failure Among High-Risk Patients With Type 2 Diabetes

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2021 to 2024Enrolled1,524ConditionsHeart Failure, Diabetes Mellitus, Type 2ArmsOn-screen electronic alert
3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 6 syntheses or guidelines pooled it, 241 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Observational
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 4 countries.

David A McAllisterInstitute of Health and Wellbeing (D.A.M.), University of Glasgow, United Kingdom.
Stephanie H ReadUsher Institute of Population Health Sciences and Informatics (S.H.R, S.H.W).
Jan KerssensNHS National Services Scotland, Edinburgh, United Kingdom (D.A.M., J.K., C.F.).
Shona LivingstoneSchool of Medicine, University of Dundee, United Kingdom (S.L.).
Stuart McGurnaghanMRC Institute of Genetics and Molecular Medicine (S.M., H.M.C).
Pardeep JhundInstitute of Cardiovascular and Medical Sciences (P.J., J.P., N.S., J.M.), University of Glasgow, United Kingdom.
John PetrieInstitute of Cardiovascular and Medical Sciences (P.J., J.P., N.S., J.M.), University of Glasgow, United Kingdom.
Naveed SattarInstitute of Cardiovascular and Medical Sciences (P.J., J.P., N.S., J.M.), University of Glasgow, United Kingdom.
Colin FischbacherNHS National Services Scotland, Edinburgh, United Kingdom (D.A.M., J.K., C.F.).
Soren Lund KristensenBispebjerg Hospital, Copenhagen University, Denmark (S.L.K.).
John McMurrayInstitute of Cardiovascular and Medical Sciences (P.J., J.P., N.S., J.M.), University of Glasgow, United Kingdom.
Helen M ColhounMRC Institute of Genetics and Molecular Medicine (S.M., H.M.C).
Sarah H WildUsher Institute of Population Health Sciences and Informatics (S.H.R, S.H.W).
National Health Service Scotland · GBInstitute of Genetics and Cancer · GBJohnson & Johnson (United Kingdom) · GBPopulation Council · INBispebjerg Hospital · DKBritish Heart Foundation · GBPt. Jawahar Lal Nehru Memorial Medical College · INUniversity of Dundee · GB

Funding

Chief Scientist Office PDF/15/07
6 · The paper itself

Abstract

backgroundRecent clinical trials of new glucose-lowering treatments have drawn attention to the importance of hospitalization for heart failure as a complication of diabetes mellitus. However, the epidemiology is not well described, particularly for type 1 diabetes mellitus. We examined the incidence and case-fatality of heart failure hospitalizations in the entire population aged ≥30 years resident in Scotland during 2004 to 2013.

methodsDate and type of diabetes mellitus diagnosis were linked to heart failure hospitalizations and deaths using the national Scottish registers. Incidence rates and case-fatality were estimated in regression models (quasi-Poisson and logistic regression respectively). All estimates are adjusted for age, sex, socioeconomic status, and calendar-year.

resultsOver the 10-year period of the study, among 3.25 million people there were 91, 429, 22 959, and 1313 incident heart failure events among those without diabetes mellitus, with type 2, and type 1 diabetes mellitus, respectively. The crude incidence rates of heart failure hospitalization were therefore 2.4, 12.4, and 5.6 per 1000 person-years for these 3 groups. Heart failure hospitalization incidence was higher in people with diabetes mellitus, regardless of type, than in people without. Relative differences were smallest for older men, in whom the difference was nonetheless large (men aged 80, rate ratio 1.78; 95% CI, 1.45-2.19). Rates declined similarly, by 0.2% per calendar-year, in people with type 2 diabetes mellitus and without diabetes mellitus. Rates fell faster, however, in those with type 1 diabetes mellitus (2.2% per calendar-year, rate ratio for type 1/calendar-year interaction 0.978; 95% CI, 0.959-0.998). Thirty-day case-fatality was similar among people with type 2 diabetes mellitus and without diabetes mellitus, but was higher in type 1 diabetes mellitus for men (odds ratio, 0.96; 95% CI, 0.95-0.96) and women (odds ratio, 0.98; 95% CI, 0.97-0.98). Case-fatality declined over time for all groups (3.3% per calendar-year, odds ratio per calendar-year 0.967; 95% CI, 0.961-0.973).

conclusionsDespite falling incidence, particularly in type 1 diabetes mellitus, heart failure remains ≈2-fold higher than in people without diabetes mellitus, with higher case-fatality in those with type 1 diabetes mellitus. These findings support the view that heart failure is an under-recognized and important complication in diabetes mellitus, particularly for type 1 disease.

Indexed as

AdultAgedAged, 80 and overCardiovascular AgentsDiabetes ComplicationsDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleHeart FailureHospitalizationHumansIncidenceLogistic ModelsMaleMiddle AgedOdds RatioCardiovascular Agentsdiabetes mellituselectronic health recordsepidemiologyheart failureincidencemortalityregistries

Identifiers

PMID29950404
PMCPMC6287897
OpenAlexW2811425937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.